<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>Microsoft Word - M Pharm PCI Syllabus all branches</title><meta name="author" content="HP"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 .p, p { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; margin:0pt; }
 .s3 { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 6pt; vertical-align: 2pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 2; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 #l2 {padding-left: 0pt;counter-reset: c2 1; }
 #l2> li>*:first-child:before {counter-increment: c2; content: counter(c2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: c2 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: d1 2; }
 #l3> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 #l4 {padding-left: 0pt;counter-reset: d2 1; }
 #l4> li>*:first-child:before {counter-increment: d2; content: counter(d2, decimal)". "; color: black; font-style: normal; font-weight: normal; text-decoration: none; }
 #l4> li:first-child>*:first-child:before {counter-increment: d2 0;  }
 li {display: block; }
 #l5 {padding-left: 0pt;counter-reset: e1 1; }
 #l5> li>*:first-child:before {counter-increment: e1; content: counter(e1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l5> li:first-child>*:first-child:before {counter-increment: e1 0;  }
 #l6 {padding-left: 0pt;counter-reset: e2 1; }
 #l6> li>*:first-child:before {counter-increment: e2; content: counter(e2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l6> li:first-child>*:first-child:before {counter-increment: e2 0;  }
 li {display: block; }
 #l7 {padding-left: 0pt;counter-reset: f1 2; }
 #l7> li>*:first-child:before {counter-increment: f1; content: counter(f1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l7> li:first-child>*:first-child:before {counter-increment: f1 0;  }
 #l8 {padding-left: 0pt;counter-reset: f2 1; }
 #l8> li>*:first-child:before {counter-increment: f2; content: counter(f2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l8> li:first-child>*:first-child:before {counter-increment: f2 0;  }
 li {display: block; }
 #l9 {padding-left: 0pt;counter-reset: g1 1; }
 #l9> li>*:first-child:before {counter-increment: g1; content: counter(g1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l9> li:first-child>*:first-child:before {counter-increment: g1 0;  }
</style><link rel="sitemap" type="application/xml" title="Sitemap" href="/sitemap.xml"></head><body><p class="s1" style="padding-top: 3pt;padding-left: 138pt;text-indent: -68pt;line-height: 113%;text-align: left;">ADVANCED INSTRUMENTAL ANALYSIS (MPA 201T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This subject deals with various hyphenated analytical instrumental techniques for identification, characterization and quantification of drugs. Instruments dealt are LC-MS, GC-MS, and hyphenated techniques.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">After completion of course student is able to know,</p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 89%;text-align: left;">  <span class="p">interpretation of the NMR, Mass and IR spectra of various organic compounds</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 10pt;text-align: left;">  <span class="p">theoretical and practical skills of the hyphenated instruments</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">identification of organic compounds</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                 60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1. <span class="s2">HPLC</span>: Principle, instrumentation, pharmaceutical applications, peak shapes, capacity factor, selectivity, plate number, plate height, resolution, band broadening, pumps, injector, detectors, columns, column problems, gradient HPLC, HPLC solvents, trouble shooting, sample preparation, method development, New developments in HPLC-role and principles of ultra, nano liquid chromatography in pharmaceutical analysis. Immobilized polysaccharide CSP’s: Advancement in enantiomeric separations, revised phase Chiral method development and HILIC approaches. HPLC in Chiral analysis of pharmaceuticals. Preparative HPLC, practical aspects of preparative HPLC.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l1"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Biochromatography<span class="p">: Size exclusion chromatography, ion exchange chromatography, ion pair chromatography, affinity chromatography general principles, stationary phases and mobile phases.</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: left;">Gas chromatography<span class="p">: Principles, instrumentation, derivatization, head space sampling, columns for GC, detectors, quantification. </span>High performance Thin Layer chromatography<span class="p">: Principles, instrumentation, pharmaceutical applications.</span></p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 9pt;text-align: left;">Super   critical   fluid   chromatography:   <span class="p">Principles,</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">instrumentation, pharmaceutical applications.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Capillary electrophoresis: <span class="p">Overview of </span>CE <span class="p">in pharmaceutical analysis, basic configuration, CE characteristics, principles of CE, methods and modes of CE. General considerations and method</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="padding-top: 2pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">development in CE, Crown ethers as buffer additives in capillary electrophoresis. CE-MS hyphenation.</p></li><li data-list-text="4"><p class="s2" style="padding-top: 1pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Mass spectrometry: <span class="p">Principle, theory, instrumentation of mass spectrometry, different types of ionization like electron impact, chemical, field, FAB and MALD, APCI, ESI, APPI mass fragmentation and its rules, meta stable ions, isotopic peaks and applications of mass spectrometry. LC-MS hyphenation and DART MS analysis. Mass analysers (Quadrpole, Time of flight, FT-ICR, ion trap and Orbitrap) instruments. MS/MS systems (Tandem: QqQ, TOF-TOF;Q-IT, Q-TOF, LTQ-FT, LTQ-Orbitrap.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">NMR spectroscopy: <span class="p">Quantum numbers and their role in NMR, Principle, Instrumentation, Solvent requirement in NMR, Relaxation process, NMR signals in various compounds, Chemical shift, Factors influencing chemical  shift, Spin-Spin coupling, Coupling constant, Nuclear magnetic double resonance, Brief outline of principles of FT-NMR with reference to 13CNMR: Spin spin and spin lattice relaxation phenomenon. 13C NMR, 1-D and 2-D NMR, NOESY and COSY techniques, Interpretation and Applications of NMR spectroscopy. LC-NMR hyphenations.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 8pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l2"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Spectrometric Identification of Organic compounds - Robert M Silverstein, Sixth edition, John Wiley &amp; Sons, 2004.</p></li><li data-list-text="2."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Principles of Instrumental Analysis - Doglas A Skoog, F. James Holler, Timothy A. Nieman, 5<span class="s3">th </span>edition, Eastern press, Bangalore, 1998.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 9pt;text-align: left;">Instrumental methods of analysis – Willards, 7<span class="s3">th </span>edition, CBS publishers.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Organic Spectroscopy - William Kemp, 3<span class="s3">rd </span>edition, ELBS, 1991.</p></li><li data-list-text="5."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Quantitative analysis of Pharmaceutical formulations by HPTLC - P D Sethi, CBS Publishers, New Delhi.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Quantitative Analysis of Drugs in Pharmaceutical formulation - P D Sethi, 3<span class="s3">rd </span>Edition, CBS Publishers, New Delhi, 1997.</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Pharmaceutical Analysis- Modern methods – Part B - J W Munson, Volume 11, Marcel Dekker Series.</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Organic Spectroscopy by Donald L. Paviya, 5th Edition.</p></li></ol></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 138pt;text-indent: -73pt;line-height: 113%;text-align: left;">MODERN BIO-ANALYTICAL TECHNIQUES (MPA 202T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">This subject is designed to provide detailed knowledge about the importance of analysis of drugs in biological matrices.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Upon completion of the course, the student shall be able to understand</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Extraction of drugs from biological samples</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Separation of drugs from biological samples using different techniques</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Guidelines for BA/BE studies.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                 60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1. <span class="s2">Extraction of drugs  and metabolites from biological matrices: </span>General need, principle and procedure involved in the Bioanalytical methods such as Protein precipitation, Liquid - Liquid extraction and Solid phase extraction and other novel sample preparation approach.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 11pt;text-align: justify;">Bioanalytical method validation: <span class="p">USFDA and EMEA guidelines.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l3"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Biopharmaceutical Consideration:</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Introduction, Biopharmaceutical Factors Affecting Drug Bioavailability, <span class="s2">In Vitro: </span>Dissolution and Drug Release Testing, Alternative Methods of Dissolution Testing Transport models, Biopharmaceutics Classification System. Solubility: Experimental methods. Permeability: <span class="s2">In-vitro, in-situ </span>and <span class="s2">In-vivo </span>methods.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Pharmacokinetics and Toxicokinetics:</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Basic consideration, Drug interaction (PK-PD interactions), The effect of protein-binding interactions, The effect of tissue-binding interactions, Cytochrome P450-based drug interactions, Drug interactions  linked  to  transporters.  Microsomal  assays Toxicokinetics-Toxicokinetic evaluation in preclinical studies, Importance and applications of toxicokinetic studies. LC-MS in bioactivity screening and proteomics.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Cell culture techniques</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Basic equipments used in cell culture lab. Cell culture media, various types of cell culture, general procedure for cell cultures; isolation of cells, subculture, cryopreservation, characterization of</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="padding-top: 2pt;padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">cells and their applications. Principles and applications of cell viability assays (MTT assays), Principles and applications of flow cytometry.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Metabolite identification:</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">In-vitro / in-vivo approaches, protocols and sample preparation. Microsomal approaches (Rat liver microsomes (RLM) and Human liver microsomes (HLM) in Met –ID. Regulatory perspectives.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">In-vitro <span class="p">assay of drug metabolites &amp; drug metabolizing enzymes.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 77%;text-align: justify;">Drug  Product  Performance,  In  Vivo:  <span class="p">Bioavailability  and Bioequivalence:</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Drug Product Performance, Purpose of Bioavailability Studies, Relative and Absolute Availability. Methods for Assessing Bioavailability, Bioequivalence Studies, Design and Evaluation of Bioequivalence Studies, Study Designs, Crossover Study Designs, Generic Biologics (Biosimilar Drug Products), Clinical Significance of Bioequivalence Studies.</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l4"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 33pt;text-indent: -14pt;line-height: 85%;text-align: left;">Analysis of drugs in Biological fluids - Joseph Chamberlain, 2<span class="s3">nd </span>Edition. CRC Press, Newyork. 1995.</p></li><li data-list-text="2."><p style="padding-top: 1pt;padding-left: 33pt;text-indent: -14pt;line-height: 85%;text-align: left;">Principles of Instrumental Analysis - Doglas A Skoog, F. James Holler, Timothy A. Nieman, 5<span class="s3">th </span>edition, Eastern press, Bangalore, 1998.</p></li><li data-list-text="3."><p style="padding-left: 33pt;text-indent: -14pt;line-height: 9pt;text-align: left;">Pharmaceutical Analysis - Higuchi, Brochmman and Hassen, 2<span class="s3">nd </span>Edition,</p><p style="padding-left: 33pt;text-indent: 0pt;line-height: 12pt;text-align: left;">Wiley – Interscience Publications, 1961.</p></li><li data-list-text="4."><p style="padding-top: 1pt;padding-left: 33pt;text-indent: -14pt;line-height: 85%;text-align: left;">Pharmaceutical Analysis- Modern methods – Part B - J W Munson, Volume 11, Marcel Dekker Series</p></li><li data-list-text="5."><p style="padding-left: 33pt;text-indent: -14pt;line-height: 87%;text-align: left;">Practical HPLC method Development – Snyder, Kirkland, Glaich, 2<span class="s3">nd </span>Edition, John Wiley &amp; Sons, New Jercy. USA.</p></li><li data-list-text="6."><p style="padding-left: 33pt;text-indent: -14pt;line-height: 88%;text-align: left;">Chromatographic Analysis of Pharmaceuticals – John A Adamovics, 2<span class="s3">nd </span>Edition, Marcel Dekker, Newyork, USA. 1997.</p></li><li data-list-text="7."><p style="padding-left: 34pt;text-indent: -15pt;line-height: 86%;text-align: left;">Chromatographic methods in clinical chemistry &amp; Toxicology – Roger L Bertholf, Ruth E Winecker, John Wiley &amp; Sons, New Jercy, USA. 2007.</p></li><li data-list-text="8."><p style="padding-left: 33pt;text-indent: -14pt;line-height: 88%;text-align: left;">Good Laboratory Practice Regulations, 2<span class="s3">nd </span>Edition, Sandy Weinberg Vol. 69, Marcel Dekker Series, 1995.</p></li><li data-list-text="9."><p style="padding-left: 33pt;text-indent: -14pt;line-height: 87%;text-align: left;">Good laboratory Practice Regulations – Allen F. Hirsch, Volume 38, Marcel Dekker Series, 1989.</p></li><li data-list-text="10."><p style="padding-left: 33pt;text-indent: -13pt;line-height: 11pt;text-align: left;">ICH, USFDA &amp; CDSCO Guidelines.</p></li><li data-list-text="11."><p style="padding-left: 33pt;text-indent: -13pt;line-height: 13pt;text-align: left;">Palmer</p></li></ol></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 52pt;text-indent: 0pt;line-height: 113%;text-align: center;">QUALITY CONTROL AND QUALITY ASSURANCE (MPA 203T)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This course deals with the various aspects of quality control and quality assurance aspects of pharmaceutical industries. It covers the important aspects like cGMP, QC tests, documentation, quality certifications, GLP and regulatory affairs.</p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 88%;text-align: left;">At the completion of this subject it is expected that the student shall be able to know</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">the cGMP aspects in a pharmaceutical industry</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">to appreciate the importance of documentation</span></p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: left;">  <span class="p">to understand the scope of quality certifications applicable to Pharmaceutical industries</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">to understand the responsibilities of QA &amp; QC departments</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 3pt;text-indent: 0pt;text-align: center;">THEORY                                 60 hrs</p><ol id="l5"><li data-list-text="1."><p class="s2" style="padding-top: 1pt;padding-left: 21pt;text-indent: -15pt;line-height: 113%;text-align: left;">Concept and Evolution of Quality Control and Quality Assurance</p><p style="padding-top: 2pt;padding-left: 21pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Good Laboratory Practice, GMP, Overview of ICH Guidelines - QSEM, with special emphasis on Q-series guidelines.</p><p class="s2" style="padding-left: 21pt;text-indent: 0pt;line-height: 89%;text-align: justify;">Good Laboratory Practices: <span class="p">Scope of GLP, Definitions, Quality assurance unit, protocol for conduct of non clinical testing, control on animal house, report preparation and documentation.</span></p></li><li data-list-text="2."><p class="s2" style="padding-top: 7pt;padding-left: 21pt;text-indent: -15pt;line-height: 106%;text-align: left;">cGMP guidelines according to schedule M, USFDA (inclusiveof CDER and CBER) Pharmaceutical Inspection Convention</p><p class="s2" style="padding-top: 5pt;padding-left: 21pt;text-indent: 0pt;line-height: 83%;text-align: justify;">(PIC), WHO and EMEA covering: <span class="p">Organization and personnel responsibilities, training, hygiene and personal records, drug industry location, design, construction and plant lay out, maintenance, sanitation, environmental control, utilities and maintenance of sterile areas, control of contamination and Good Warehousing Practice. CPCSEA guidelines.</span></p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">12</p><p class="s2" style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">12</p><p class="s2" style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3."><p class="s2" style="padding-top: 4pt;padding-left: 21pt;text-indent: -15pt;line-height: 115%;text-align: justify;">Analysis of  raw  materials,  finished  products,  packaging materials,  in  process  quality  control  (IPQC),  Developing specification (ICH Q6 and Q3)</p><p class="s2" style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">12</p><p class="s2" style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Hrs</p><p style="padding-top: 2pt;padding-left: 21pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Purchase specifications and maintenance of stores for raw materials. In process quality control and finished products quality control for following formulation in Pharma industry according to Indian, US and British pharmacopoeias: tablets, capsules, ointments, suppositories, creams, parenterals, ophthalmic and surgical products (How to refer pharmacopoeias), Quality control test for containers, closures and secondary packing materials.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4."><p class="s2" style="padding-left: 21pt;text-indent: -15pt;line-height: 86%;text-align: justify;">Documentation  in  pharmaceutical  industry:  <span class="p">Three  tier documentation, Policy, Procedures and Work instructions, and records (Formats), Basic principles- How to maintain, retention and retrieval etc. Standard operating procedures (How to write), Master Formula Record, Batch Formula Record, Quality audit plan and reports. Specification and test procedures, Protocols and reports. Distribution records. Electronic data.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5."><p class="s2" style="padding-left: 21pt;text-indent: -15pt;line-height: 86%;text-align: justify;">Manufacturing  operations  and  controls:  <span class="p">Sanitation   of manufacturing premises, mix-ups and cross contamination, processing of intermediates and bulk products, packaging operations, IPQC, release of finished product, process deviations, charge-in of components, time limitations on production, drug product inspection, expiry date calculation, calculation of yields, production record review, change control, sterile products, aseptic process control, packaging.</span></p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">12</p><p class="s2" style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">12</p><p class="s2" style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Hrs</p><ol id="l6"><li data-list-text="1."><p style="padding-top: 4pt;padding-left: 26pt;text-indent: -14pt;line-height: 83%;text-align: left;">Quality Assurance Guide by organization of Pharmaceutical Procedures of India, 3<span class="s3">rd </span>revised edition, Volume I &amp; II, Mumbai, 1996.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 88%;text-align: left;">Good Laboratory Practice Regulations, 2<span class="s3">nd </span>Edition, Sandy Weinberg Vol. 69, Marcel Dekker Series, 1995.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Quality Assurance of Pharmaceuticals- A compedium of Guide lines and Related materials Vol I &amp; II, 2<span class="s3">nd </span>edition, WHO Publications, 1999.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">How to Practice GMP’s – P P Sharma, Vandana Publications, Agra, 1991.</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">The International Pharmacopoeia – vol I, II, III, IV &amp; V - General Methods</p><p style="padding-top: 1pt;padding-left: 26pt;text-indent: 0pt;line-height: 86%;text-align: left;">of Analysis and Quality specification for Pharmaceutical Substances, Excepients and Dosage forms, 3<span class="s3">rd </span>edition, WHO, Geneva, 2005.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 9pt;text-align: left;">Good laboratory Practice Regulations – Allen F. Hirsch, Volume 38, Marcel</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 12pt;text-align: left;">Dekker Series, 1989.</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">ICH guidelines</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">ISO 9000 and total quality management</p></li><li data-list-text="9."><p style="padding-top: 4pt;padding-left: 26pt;text-indent: -14pt;line-height: 71%;text-align: justify;">The drugs and cosmetics act 1940 – Deshpande, Nilesh Gandhi, 4<span class="s3">th </span>edition, Susmit Publishers, 2006.</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: justify;">QA Manual – D.H. Shah, 1<span class="s3">st </span>edition, Business Horizons, 2000.</p></li><li data-list-text="11."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: justify;">Good Manufacturing Practices for Pharmaceuticals a plan for total quality control – Sidney H. Willig, Vol. 52, 3<span class="s3">rd </span>edition, Marcel Dekker Series.</p></li><li data-list-text="12."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Steinborn L. GMP/ISO Quality Audit Manual for Healthcare Manufacturers and Their Suppliers, Sixth Edition, (Volume 1 - With Checklists and Software Package). Taylor &amp; Francis; 2003.</p></li><li data-list-text="13."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 9pt;text-align: justify;">Sarker DK. Quality Systems and Controls for Pharmaceuticals. John Wiley</p></li></ol></li></ol><p style="padding-left: 26pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">&amp; Sons; 2008.</p><p class="s1" style="padding-top: 3pt;padding-left: 138pt;text-indent: -60pt;line-height: 113%;text-align: left;">HERBAL AND COSMETIC ANALYSIS (MPA 204T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This course is designed to impart knowledge on analysis of herbal products. Regulatory requirements, herbal drug interaction with monographs. Performance evaluation of cosmetic products is included for the better understanding of the equipments used in cosmetic industries for the purpose.</p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;line-height: 13pt;text-align: center;">At completion of this course student shall be able to understand</p><p class="s2" style="padding-left: 3pt;text-indent: 0pt;line-height: 12pt;text-align: center;">  <span class="p">Determination of herbal remedies and regulations</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Analysis of natural products and monographs</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Determination of Herbal drug-drug interaction</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Principles of performance evaluation of cosmetic products.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                 60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1.  <span class="s2">Herbal  remedies-  Toxicity  and  Regulations:  </span>Herbals  vs Conventional drugs, Efficacy of herbal medicine products, Validation of Herbal Therapies, Pharmacodynamic and Pharmacokinetic issues. Herbal drug standardization<span class="s2">: </span>WHO and AYUSH guidelines.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l7"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Adulteration  and  Deterioration:  <span class="p">Introduction,  types  of adulteration/substitution of herbal drugs, Causes and Measure of adulteration, Sampling Procedures, Determination of Foreign Matter, DNA Finger printing techniques in identification of drugs of natural origin, heavy metals, pesticide residues, phototoxin and microbial contamination in herbal formulations.</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 7pt;text-align: justify;">Regulatory requirements for setting herbal drug industry:</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Global marketing management, Indian and international patent law as applicable herbal drugs and natural products and its protocol.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Testing of natural products and drugs: <span class="p">Effect  of  herbal medicine on clinical laboratory testing, Adulterant Screening using modern analytical instruments, Regulation and dispensing of herbal drugs, Stability testing of natural products, protocol.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 89%;text-align: justify;">Monographs of Herbal drugs: <span class="p">Study of monographs of herbal drugs and comparative study in IP, USP, Ayurvedic</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="padding-top: 2pt;padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Pharmacopoeia, American herbal Pharmacopoeia, British herbal Pharmacopoeia, Siddha and Unani Pharmacopoeia, WHO guidelines in quality assessment of herbal drugs.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Herbal drug-drug interaction: <span class="p">WHO and AYUSH guidelines for safety monitoring of natural medicine, Spontaneous reporting schemes for bio drug adverse reactions, bio drug-drug and bio drug-food interactions with suitable examples. Challenges in monitoring the safety of herbal medicines.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Evaluation of cosmetic products<span class="p">: Determination of acid value, ester value, saponification value, iodine value, peroxide value, rancidity, moisture, ash, volatile matter, heavy metals, fineness of powder, density, viscosity of cosmetic raw materials and finished products. Study of quality of raw materials and general methods of analysis of raw material used in cosmetic manufacture as per BIS.</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Indian Standard specification laid down for sampling and testing of various cosmetics in finished forms such as baby care products, skin care products, dental products, personal hygiene preparations, lips sticks. Hair products and skin creams by the Bureau Indian Standards.</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l8"><li data-list-text="1."><p style="padding-top: 2pt;padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Pharmacognosy by Trease and Evans</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Pharmacognosy by Kokate, Purohit and Gokhale</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Quality Control Methods for Medicinal Plant, WHO, Geneva</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Pharmacognosy &amp; Pharmacobiotechnology by Ashutosh Kar</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Essential of Pharmacognosy by Dr.S.H.Ansari</p></li><li data-list-text="6."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 84%;text-align: left;">Cosmetics – Formulation, Manufacturing and Quality Control, P.P. Sharma, 4<span class="s3">th </span>edition, Vandana  Publications Pvt. Ltd., Delhi</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Indian Standard specification, for raw materials, BIS, New Delhi.</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Indian Standard specification for 28 finished cosmetics BIS, New Delhi</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Harry’s Cosmeticology 8th edition</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Suppliers catalogue on specialized cosmetic excipients</p></li><li data-list-text="11."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Wilkinson, Moore, seventh edition, George Godwin. Poucher’s Perfumes, Cosmetics and Soaps</p></li><li data-list-text="12."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 83%;text-align: left;">Hilda Butler, 10th Edition, Kluwer Academic Publishers. Handbook of Cosmetic Science and Technology, 3rd Edition,</p></li></ol></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 141pt;text-indent: -85pt;line-height: 113%;text-align: left;">PHARMACEUTICAL ANALYSIS PRACTICALS - I (MPA 205P)</p><ol id="l9"><li data-list-text="1."><p style="padding-left: 28pt;text-indent: -18pt;line-height: 13pt;text-align: left;">Comparison of absorption spectra by UV and Wood ward – Fiesure rule</p></li><li data-list-text="2."><p style="padding-left: 28pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Interpretation of organic compounds by FT-IR</p></li><li data-list-text="3."><p style="padding-left: 28pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Interpretation of organic compounds by NMR</p></li><li data-list-text="4."><p style="padding-left: 28pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Interpretation of organic compounds by MS</p></li><li data-list-text="5."><p style="padding-left: 28pt;text-indent: -18pt;line-height: 13pt;text-align: left;">Determination of purity by DSC in pharmaceuticals</p></li><li data-list-text="6."><p style="padding-top: 1pt;padding-left: 28pt;text-indent: -18pt;line-height: 85%;text-align: left;">Identification of organic compounds using FT-IR, NMR, CNMR and Mass spectra</p></li><li data-list-text="7."><p style="padding-left: 28pt;text-indent: -18pt;line-height: 86%;text-align: left;">Bio molecules separation utilizing various sample preparation techniques and Quantitative analysis of components by gel electrophoresis.</p></li><li data-list-text="8."><p style="padding-left: 28pt;text-indent: -18pt;line-height: 87%;text-align: left;">Bio molecules separation utilizing various sample preparation techniques and Quantitative analysis of components by HPLC techniques.</p></li><li data-list-text="9."><p style="padding-left: 28pt;text-indent: -18pt;line-height: 11pt;text-align: left;">Isolation of analgesics from biological fluids (Blood serum and urine).</p></li><li data-list-text="10."><p style="padding-left: 28pt;text-indent: -18pt;line-height: 86%;text-align: left;">Protocol preparation and performance of analytical/Bioanalytical method validation.</p></li><li data-list-text="11."><p style="padding-left: 28pt;text-indent: -18pt;line-height: 86%;text-align: left;">Protocol preparation for the conduct of BA/BE studies according to guidelines.</p></li><li data-list-text="12."><p style="padding-left: 28pt;text-indent: -18pt;line-height: 86%;text-align: left;">In process and finished product quality control tests for tablets, capsules, parenterals and creams</p></li><li data-list-text="13."><p style="padding-left: 27pt;text-indent: -17pt;line-height: 11pt;text-align: left;">Quality control tests for Primary and secondary packing materials</p></li><li data-list-text="14."><p style="padding-left: 27pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Assay of raw materials as per official monographs</p></li><li data-list-text="15."><p style="padding-left: 27pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Testing of related and foreign substances in drugs and raw materials</p></li><li data-list-text="16."><p style="padding-left: 27pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Preparation of Master Formula Record.</p></li><li data-list-text="17."><p style="padding-left: 27pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Preparation of Batch Manufacturing Record.</p></li><li data-list-text="18."><p style="padding-left: 27pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Quantitative analysis of rancidity in lipsticks and hair oil</p></li><li data-list-text="19."><p style="padding-left: 27pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Determination of aryl amine content and Developer in hair dye</p></li><li data-list-text="20."><p style="padding-left: 27pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Determination of foam height and SLS content of Shampoo.</p></li><li data-list-text="21."><p style="padding-left: 27pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Determination of total fatty matter in creams (Soap, skin and hair creams)</p></li><li data-list-text="22."><p style="padding-left: 27pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Determination of acid value and saponification value.</p></li><li data-list-text="23."><p style="padding-left: 27pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Determination of calcium thioglycolate in depilatories</p></li></ol></body></html>
